These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9853078)

  • 1. [Growth hormone deficiency. Treatment with growth hormone and body composition].
    Antoniazzi F; Zamboni G; Radetti G; Mengarda F; Lauriola S; Serra A; Tatò L
    Arch Pediatr; 1998; 5 Suppl 4():327S-331S. PubMed ID: 9853078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents with partial growth hormone (GH) deficiency develop alterations of body composition after GH discontinuation and require follow-up.
    Tauber M; Jouret B; Cartault A; Lounis N; Gayrard M; Marcouyeux C; Pienkowski C; Oliver I; Moulin P; Otal P; Joffre F; Arnaud C; Rochiccioli P
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5101-6. PubMed ID: 14602733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
    Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in body composition after cessation of growth hormone therapy in childhood-onset growth hormone deficiency.
    Bechtold S; Bachmann S; Putzker S; Dalla Pozza R; Schwarz HP
    J Clin Densitom; 2011; 14(4):471-7. PubMed ID: 21723762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
    Whitehead HM; Boreham C; McIlrath EM; Sheridan B; Kennedy L; Atkinson AB; Hadden DR
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):45-52. PubMed ID: 1559299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
    van der Sluis IM; Boot AM; Hop WC; De Rijke YB; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional care of GH deficiency: when to stop GH therapy.
    Savage MO; Drake WM; Carroll PV; Monson JP
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S61-5. PubMed ID: 15339246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Body composition and metabolic risk in small for gestational age children treated with growth hormone].
    Aurensanz Clemente E; Samper Villagrasa P; Ayerza Casas A; Ruiz Frontera P; Moreno Aznar LA; Bueno Lozano G
    Med Clin (Barc); 2016 Sep; 147(6):231-7. PubMed ID: 27423655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning of children with GH deficiency to adult dosing: changes in body composition.
    Nguyen VT; Misra M
    Pituitary; 2009; 12(2):125-35. PubMed ID: 18373203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
    Woodhouse LJ; Mukherjee A; Shalet SM; Ezzat S
    Endocr Rev; 2006 May; 27(3):287-317. PubMed ID: 16543384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
    Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of discontinuing growth hormone treatment.
    Cowan FJ; Evans WD; Gregory JW
    Arch Dis Child; 1999 Jun; 80(6):517-23. PubMed ID: 10331999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult growth hormone deficiency.
    Jørgensen JO; Müller J; Møller J; Wolthers T; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
    Horm Res; 1994; 42(4-5):235-41. PubMed ID: 7868079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.